Fact Sheet PDF

Share Graph

Share Data

08/05/2025

Currency	JPY
Previous Close	2,190
Change (%)	4.69

Volume	3,027,400
Number of Shares ( mil)	525.63
Market Cap ( mil)	1,150,876.74

Latest press releases

07/05/2025	Introduction of Special Voluntary Early Retirement Program
01/05/2025	Announcement of Consolidated Financial Results Fiscal 2025 First Quarter
11/04/2025	Kyowa Kirin Completed Construction of a New Biopharmaceutical DS Manufacturing Facility at Takasaki Plant-Acceleration of development through the establishment of an innovative global manufacturing structure
08/04/2025	Kura Oncology and Kyowa Kirin Announce Submission of New Drug Application for Ziftomenib to FDA
08/03/2025	AMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
07/03/2025	Kyowa Kirin Announces Approval for Partial Change of Rituximab Biosimilar Received by Sandoz in Japan
27/02/2025	Kyowa Kirin Announces Late-Breaking Abstract Presentation at the American Academy of Dermatology Annual Meeting 2025
06/02/2025	Announcement of Consolidated Financial Results Fiscal 2024
06/02/2025	Kyowa Kirin Announces Changes in Directors and Auditors
06/02/2025	Kura Oncology and Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial and Positive FDA Feedback for Upcoming Frontline Combination Trial Designs
20/01/2025	Kyowa Kirin Received Prime Minister’s Award for Japan Medical Research and Development Grand Prize
24/12/2024	Kyowa Kirin Announces Newly Established Chief Digital Transformation Officer (CDXO)

Company presentation

Kyowa Kirin is an R&D-based life sciences company with special strengths in biotechnology. The Kyowa Kirin Group companies strive to contribute to the health and well-being of people around the world by creating new value through the pursuit of advances in life sciences and technologies.